FRAN BRIDGES: Open Payments
NPI 1538487079 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 91 payments from 22 companies in 2025. Trend: 2023 $826 · 2024 $1,049 · 2025 $2,167
Food & beverage: $2,167
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $285 |
| GENZYME CORPORATION | 10 | $245 |
| Insmed, Inc. | 8 | $172 |
| GlaxoSmithKline, LLC. | 12 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $166 |
| Pulmonx Corporation | 1 | $129 |
| Verona Pharma, Inc. | 5 | $117 |
| Regeneron Healthcare Solutions, Inc. | 6 | $114 |
| Lilly USA, LLC | 2 | $106 |
| JAZZ PHARMACEUTICALS INC. | 4 | $99 |
Products named: DUPIXENT, Arikayce, BREZTRI, CHARTIS CATHETER, Ohtuvayre, NUCALA, XYWAV, FASENRA.
Industry payments across FL — which companies pay providers there.
